Neon Therapeutics (NTGN) Stock’s Ratio Analysis:
Long Term Debt/Equity ratio was recorded at 0. This measures a company’s financial leverage calculated by dividing its long term debt by stockholders’ equity. It indicates what proportion of equity and debt the company is using to finance its assets. On the other side the debt to equity ratio is 0. Its current ratio is 15.4. Current Ratio is a liquidity ratio that measures a company’s ability to pay short-term obligations. Quick Ratio of 15.4 is an indicator of a company’s short-term liquidity. The quick ratio measures a company’s ability to meet its short-term obligations with its most liquid assets. The higher the quick ratio, the better the position of the company.
Let’s consider Neon Therapeutics (NTGN) stock move that changed on Friday Dated OCTOBER 12, 2018. 145342 shares changed at hands in last session versus to an average volume of 126.67K shares. Neon Therapeutics (NTGN) stock ended at $9.06 by scoring -8.67%. It has 27.63M outstanding shares and 24.28M shares have been floated in market exchange. The stock institutional ownership included 66.30% while insider ownership remained 3.50%. The net percent change held by Institutional Investors has seen a change of 0.32% over last three month period.
Stock’s Price Fluctuations & Volatility:
The stock price registered volatility 10.94% in past week and volatility was at 16.28% over a last month. Historical volatility refers to the price fluctuations exhibited by the underlying asset (such as stock) over time. A security with high volatility has bigger fluctuations in price compared to a security with low volatility. The more quickly a price changes up and down, the more volatile it is. As such, volatility is often used as a measure of risk.
The stock’s Average True Range for 14 days was 1.31. ATR measures volatility, taking into account any gaps in the price movement. High ATR indicates increased volatility. A low ATR value indicates a series of periods with small ranges. Presently, (NTGN) has a RSI reading of 43.28.
Neon Therapeutics (NTGN) Stock’s Moving Average & Performance Analysis:
The stock showed weekly performance of -16.96% and it maintained for the month at -6.60%. Likewise the performance for the quarter was recorded as -18.01%. The YTD performance remained at -39.60%. This stock traded upward toward its 52 week low with 46.84% and -44.18% negative from its 52 week high price. The stock price is moving down from its 20 days moving average with -1.49% and it is trading down from 50 days moving average with -15.09%. The stock price is moving along declining drift from its 200 days moving average with -18.63%.